January 24, 2022
Decision Day marks the moment when thousands of incoming Bearcats learn they’ve been accepted to the University of Cincinnati. University officials surprised four area high school seniors at their schools and homes, making them among the first to be accepted into UC in 2022.
October 6, 2022
The University of Cincinnati is committing $12 million to grow inclusive excellence by leveraging diverse perspectives to advance innovation, creativity and complex problem solving in biomedical research. The new program, FIRST+ Lives Here for Urban Health, aligns with the National Institutes of Health’s FIRST (Faculty Institutional Recruitment for Sustainable Transformation) Program and advances the university’s Next Lives Here strategic direction.
September 11, 2023
UC physician-scientist Jordan Kharofa, MD, is leading a clinical trial to improve treatment outcomes for anal cancer patients. The effort has received support from Ride Cincinnati, a important backer of the University of Cincinnati Cancer Center.
February 7, 2023
The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.
November 17, 2022
According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
January 22, 2021
Researchers at the University of Cincinnati have tested a new combination therapy in head and neck cancer animal models to see if they could find a way to make an already effective treatment even better.
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).